ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,244, issued on Sept. 9, was assigned to UCB Biopharma SRL (Brussels).
"Anti-alpha-synuclein antibodies" was invented by Patrick Downey (Brussels), Kerry Louise Tyson (Slough, Great Britain), Marco Kriek (Slough, Great Britain), Lorenzo De Lichtervelde (Brussels), Daniel John Lightwood (Slough, Great Britain), David James Mcmillan (Slough, Great Britain), Peter Charles Elliott (Slough, Great Britain) and Terence Seward Baker (Berkshire, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to alpha synuclein binding antibodies and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils an...